# EDGAR Filing Document

**Accession Number:** 0001840877
**File Stem:** 0001104659-26-015955
**Filing Date:** 2026-2
**Character Count:** 7158
**Document Hash:** c331a552e97b492b25129afde6865398
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-015955.hdr.sgml**: 20260217

**ACCESSION NUMBER**: 0001104659-26-015955

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260217

**DATE AS OF CHANGE**: 20260217

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Envoy Medical, Inc.
- **CENTRAL INDEX KEY:** 0001840877
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 861369123
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93483
- **FILM NUMBER:** 26637033

**BUSINESS ADDRESS:**
- **STREET 1:** 4875 WHITE BEAR PARKWAY
- **CITY:** WHITE BEAR LAKE
- **STATE:** MN
- **ZIP:** 55110
- **BUSINESS PHONE:** 651-361-8000

**MAIL ADDRESS:**
- **STREET 1:** 4875 WHITE BEAR PARKWAY
- **CITY:** WHITE BEAR LAKE
- **STATE:** MN
- **ZIP:** 55110

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Anzu Special Acquisition Corp I
- **DATE OF NAME CHANGE:** 20210115
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TAYLOR GLEN A
- **CENTRAL INDEX KEY:** 0001213971

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** C/O TAYLOR CORP
- **STREET 2:** 1725 ROE CREST DR
- **CITY:** N MANKALO
- **STATE:** MN
- **ZIP:** 56002

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Envoy Medical, Inc.**

*(Name of Issuer)*

**Class A Common Stock**

*(Title of Class of Securities)*

**29415V109**

*(CUSIP Number)*

**Brian A. Mayer, Esq.**<br>Taylor Corporation<br>1725 Roe Crest Drive<br>North Mankato MN 56003<br>507.386.3193

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/12/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **29415V109** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Glen A. Taylor** | Name of reporting person<br>**Glen A. Taylor** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**68909614.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**68909614.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**68909614.00** | Aggregate amount beneficially owned by each reporting person<br>**68909614.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**84.8%** | Percent of class represented by amount in Row (11)<br>**84.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock

**(b) Name of Issuer:**
Envoy Medical, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
4875 White Bear Parkway, White Bear Lake, MN, 55110

This Amendment No. 1 to Schedule 13D (this "Amendment") is being filed by Glen A. Taylor (the "Reporting Person") to amend and supplement certain Items of that the Schedule 13D filed with the Securities and Exchange Commission ("SEC") on December 8, 2025 (the "Original Schedule 13D"). Information contained in the Original Schedule 13D, remains effective except to the extent that it is amended, restated, supplemented, or superseded by the information contained in this Amendment. Capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 is hereby amended to read as follows:

The information set forth in the cover pages and Item 3 of this Schedule 13D are incorporated herein by reference.

As of February 12, 2025, the Reporting Person beneficially owns an aggregate of 68,909,614 shares of Class A Common Stock, which represents 84.8% of the Class A Common Stock based upon an aggregate of 76,881,110 shares of Class A Common Stock outstanding immediately following the Company's offering, as reported in the Company's Prospectus dated February 11, 2026, filed with the SEC on February 12, 2026. Although the Common Warrants are exercisable only after the Stockholder Approval Date such that the Reporting Person may not have a right to acquire the Class A Common Stock underlying the Common Warrants within 60 days, for the purposes of this Amendment, the shares of Class A Common Stock underlying the Common Warrants are treated as beneficially owned by the Reporting Person.

As of February 12, 2025, the Reporting Person holds an aggregate of 29,040,049 shares of Class A Common Stock, which represents 37.7% of the 76,881,110 shares of Class A Common Stock outstanding immediately following the Company's offering.

**(b)**
The Reporting Person has sole voting and sole dispositive power over all shares beneficially owned.

**(c)**
Except as reported in this Amendment, the Reporting Person has not made any transactions in the Company's securities within the prior 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 is hereby is hereby amended by adding the following as the last paragraph thereof:

Information with respect to the Common Warrants purchased by the Reporting Person on February 12, 2026 is incorporated herein by reference to Item 3 and to the respective forms of the Series A-1 Warrant and Series A-2 Warrant incorporated by reference in Item 7 hereof.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Glen A. Taylor

**Signature:** /s/ Glen Taylor

**Name/Title:** Glen A. Taylor

**Date:** 02/16/2026